154 related articles for article (PubMed ID: 9068943)
1. Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats.
Bollineni JS; Alluru I; Reddi AS
Curr Eye Res; 1997 Feb; 16(2):127-30. PubMed ID: 9068943
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP regulates basement membrane heparan sulfate proteoglycan, perlecan, metabolism in rat glomerular epithelial cells.
Ko CW; Bhandari B; Yee J; Terhune WC; Maldonado R; Kasinath BS
Mol Cell Biochem; 1996 Sep; 162(1):65-73. PubMed ID: 8905627
[TBL] [Abstract][Full Text] [Related]
3. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
Klein DJ; Oegema TR; Brown DM
Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
[TBL] [Abstract][Full Text] [Related]
4. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
Kasinath BS; Grellier P; Choudhury GG; Abboud SL
J Cell Physiol; 1996 Apr; 167(1):131-6. PubMed ID: 8698830
[TBL] [Abstract][Full Text] [Related]
5. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
Templeton DM
Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
[TBL] [Abstract][Full Text] [Related]
7. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
Klein DJ; Brown DM; Oegema TR
Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
[TBL] [Abstract][Full Text] [Related]
8. Increased retinal synthesis of heparan sulfate proteoglycan and HNK-1 glycoproteins following photoreceptor degeneration.
Landers RA; Rayborn ME; Myers KM; Hollyfield JG
J Neurochem; 1994 Aug; 63(2):737-50. PubMed ID: 8035198
[TBL] [Abstract][Full Text] [Related]
9. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina.
Hammes HP; Weiss A; Hess S; Araki N; Horiuchi S; Brownlee M; Preissner KT
Lab Invest; 1996 Sep; 75(3):325-38. PubMed ID: 8804356
[TBL] [Abstract][Full Text] [Related]
10. Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies.
Witmer AN; van den Born J; Vrensen GF; Schlingemann RO
Curr Eye Res; 2001 Mar; 22(3):190-7. PubMed ID: 11462155
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.
Vernier RL; Steffes MW; Sisson-Ross S; Mauer SM
Kidney Int; 1992 Apr; 41(4):1070-80. PubMed ID: 1513088
[TBL] [Abstract][Full Text] [Related]
12. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
[TBL] [Abstract][Full Text] [Related]
13. Decreased glomerular basement membrane heparan sulfate proteoglycan in essential hypertension.
Heintz B; Stöcker G; Mrowka C; Rentz U; Melzer H; Stickeler E; Sieberth HG; Greiling H; Haubeck HD
Hypertension; 1995 Mar; 25(3):399-407. PubMed ID: 7875766
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the existence of multiple heparan sulfate proteoglycans in the human glomerular basement membrane and mesangial matrix.
Groffen AJ; Hop FW; Tryggvason K; Dijkman H; Assmann KJ; Veerkamp JH; Monnens LA; Van den Heuvel LP
Eur J Biochem; 1997 Jul; 247(1):175-82. PubMed ID: 9249024
[TBL] [Abstract][Full Text] [Related]
15. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
16. Analysis of proteoglycan expression in developing chicken brain: characterization of a heparan sulfate proteoglycan that interacts with the neural cell adhesion molecule.
Burg MA; Halfter W; Cole GJ
J Neurosci Res; 1995 May; 41(1):49-64. PubMed ID: 7674377
[TBL] [Abstract][Full Text] [Related]
17. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice.
Rohrbach DH; Wagner CW; Star VL; Martin GR; Brown KS; Yoon JW
J Biol Chem; 1983 Oct; 258(19):11672-7. PubMed ID: 6225778
[TBL] [Abstract][Full Text] [Related]
18. Basement membrane proteoglycans are of epithelial origin in rodent skin.
Yamane Y; Yaoita H; Couchman JR
J Invest Dermatol; 1996 Mar; 106(3):531-7. PubMed ID: 8648189
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
Gambaro G; Venturini AP; Noonan DM; Fries W; Re G; Garbisa S; Milanesi C; Pesarini A; Borsatti A; Marchi E
Kidney Int; 1994 Sep; 46(3):797-806. PubMed ID: 7527876
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues.
Couchman JR
J Cell Biol; 1987 Oct; 105(4):1901-16. PubMed ID: 2959669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]